Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Signalling targets for anticancer drug development.

G Powis1

  • 1Department of Pharmacology, Mayo Clinic and Foundation, Rochester, MN 55905.

Trends in Pharmacological Sciences
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PATHOME: an algorithm for accurately detecting differentially expressed subpathways.

Oncogene·2014
Same author

PI-3-Kinase inhibitors in colorectal cancer.

Current cancer drug targets·2010
Same author

In vitro metabolism of [(3)H]2,6-dinitrotoluene by human and rat liver.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Adenine and pyridine nucleotide concentrations and relationships to 2,6-dinitrotoluene metabolism in cultured rat liver slices.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Increased thioredoxin-1 inhibits SSAT expression in MCF-7 human breast cancer cells.

Biochemical and biophysical research communications·2003
Same author

DNA microarray reveals increased expression of thioredoxin peroxidase in thioredoxin-1 transfected cells and its functional consequences.

Advances in experimental medicine and biology·2002
Same journal

Structural pharmacology of TRPA1 channel.

Trends in pharmacological sciences·2026
Same journal

Recent advances in venom pharmacology reshaping venom-to-drug discovery.

Trends in pharmacological sciences·2026
Same journal

Engineering cells for solid tumor therapy.

Trends in pharmacological sciences·2026
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
See all related articles

Targeting intracellular signaling pathways offers a promising strategy for developing novel anticancer drugs. Research into these pathways, including those involving growth factors and oncogenes, is leading to more selective cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Intracellular signaling pathways regulate cell growth and transformation.
  • Growth factors and oncogenes are key mediators of these pathways.
  • Targeting these pathways presents a novel approach for anticancer drug development.

Purpose of the Study:

  • To review the evidence for targeting intracellular signaling pathways in cancer therapy.
  • To highlight existing and potential drug targets within these pathways.
  • To discuss the future prospects of this therapeutic strategy.

Main Methods:

  • Literature review of current research on intracellular signaling in cancer.
  • Analysis of existing drugs targeting kinases and phospholipase C.

Related Experiment Videos

  • Discussion of emerging targets in myo-inositol signaling.

    • Main Results:

    • Several drug classes, including kinase inhibitors and phospholipase C inhibitors, are already utilized.
    • Understanding of growth control signaling is expanding, revealing new therapeutic targets.
    • Pharmacological intervention in these pathways shows potential for selective anticancer effects.

    Conclusions:

    • Targeting intracellular signaling pathways is a viable and evolving strategy for anticancer drug development.
    • Continued research will identify new, more selective therapeutic targets.
    • This approach holds promise for the future of cancer treatment.